By Lily Kelly Contributing Writer Hope is on the horizon for needle phobics as researchers from Griffith University have ...

Silo Pharma (NASDAQ: SILO) has entered into a collaboration with Kymanox to develop a subcutaneous insertion device for SP-26, its ketamine-loaded ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and UroGen Pharma (NASDAQ:URGN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two ...

Prototype development and feasibility testing underway for optimized subcutaneous deliverySARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo ...

The following is a summary of “Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies,” published in the ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced an extension of its cooperative research and development agreement ...

Undocumented or subclinical influenza cases may explain why those who receive repeat influenza vaccines over multiple seasons ...

The Amphastar Pharmaceuticals' logo and other trademarks or service marks of Amphastar Pharmaceuticals, Inc., including, but not limited to Primatene MIST ®, Amphadase ®, Cortrosyn ®, REXTOVY ® and ...